Assessing the Dependence of Feeding Gastrostomy Tube in Patients of Head and Neck Carcinomas
DOI:
https://doi.org/10.51253/pafmj.v74i1.9886Keywords:
Esophagus, Radiotherapy, Neoplasms, Drug therapy, Gastrostomy, Head and neck neoplasmsAbstract
Objective: To investigate the dependency on feeding gastrostomy tubes in patients with head and neck cancers treated with radiotherapy alone or concurrent chemo-radiotherapy.
Study Design: Retrospective longitudinal study.
Place and Duration of Study: Combined Military Hospital, Rawalpindi and Shaukat Khanum Hospital, Peshawar Pakistan,
from Jan and Jul 2022.
Methodology: A total of 115 patients with head and neck cancers having no baseline dysphagia and having gastrostomy tubes were included. All had received an equivalent of 60 greys in 30 fractions or more of radiotherapy. Their swallowing was evaluated weekly during radiotherapy and then every 4–6 weeks on post-treatment follow-up. The total time duration of patient dependency on feeding gastrostomy tube after treatment completion was noted for each head and neck cancer subsite.
Results: Of a total of 115 patients, 49(43%) of the patients had nasopharyngeal cancers, 22(19%) had laryngeal, 29(24%) oral cavity, 7(6%) hypopharyngeal and 9(8%) had cervical esophageal cancers. Proportion retaining gastrostomy tube for more than six months of treatment was 8.7% (median duration of retention was five months) with hypopharyngeal,
nasopharyngeal, oral cavity, and laryngeal cancer were 14%, 9%, 9% and 5%, respectively.
Conclusion: The proportion of patients with head and neck cancers requiring more than six months of a gastrostomy tube is 5-14%. Baseline assessment of swallowing and nutrition and prophylactic feeding gastrostomy can avoid treatment
interruptions. Longer duration of retention of a gastrostomy tube is associated with poor quality of life in head and neck
cancer patients receiving radiation or concurrent chemo-radiation.
Downloads
References
Sung H, FerlayJ, Siegel RL, Laversanne M, Soerjomataram I,
Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN
Estimates of Incidence and Mortality Worldwide for 36 Cancers
in 185 Countries. CA Cancer J Clin 2021; 71(3): 209-249.
https://doi.org/10.3322/caac.21660.
González-Rodríguez M, Villar-Taibo R, Fernández-Pombo A,
Pazos-Couselo M, Sifontes-Dubón MA, Ferreiro-Fariña S, et al.
Early versus conventional nutritional intervention in head and
neck cancer patients before radiotherapy: benefits of a fast-track
circuit. Eur J Clin Nutr 2021; 75(5): 748-753.
https://doi.org/10.1038/s41430-020-00786-1.
Nguyen NP, Smith HJ, Sallah S. Evaluation and management of
swallowing dysfunction following chemoradiation for head and
neck cancer. Curr Opin Otolaryngol Head Neck Surg. 2007; 15(2):
-133. https://doi.org/10.1097/MOO.0b013e32801da0e8.
Pignon JP, le Maître A, Maillard E, Bourhis J; MACH-NC
Collaborative Group. Meta-analysis of chemotherapy in head
and neck cancer (MACH-NC): an update on 93 randomised trials
and 17,346 patients. Radiother Oncol 2009; 92(1): 4-14.
https://doi.org/10.1016/j.radonc.2009.04.014.
Bourhis J, Sire C, Graff P, Grégoire V, Maingon P, Calais G, et al.
Concomitant chemoradiotherapy versus acceleration of
radiotherapy with or without concomitant chemotherapy in
locally advanced head and neck carcinoma (GORTEC 99-02): an
open-label phase 3 randomised trial. Lancet Oncol 2012; 13(2):
-153. https://doi.org/10.1016/S1470-2045(11)70346-1.
Setton J, Lee NY, Riaz N, Huang SH, Waldron J, O'Sullivan B, et
al. A multi-institution pooled analysis of gastrostomy tube
dependence in patients with oropharyngeal cancer treated with
definitive intensity-modulated radiotherapy. Cancer 2015; 121(2):
-301. https://doi.org/10.1002/cncr.29022.
Chera BS, Amdur RJ, Green R, Shen C, Gupta G, Tan X, et al.
Phase II Trial of De-Intensified Chemoradiotherapy for Human
Papillomavirus-Associated Oropharyngeal Squamous Cell
Carcinoma. J Clin Oncol 2019; 37(29): 2661-2669.
https://doi.org/10.1200/JCO.19.01007.
Beaver ME, Matheny KE, Roberts DB, Myers JN. Predictors of
weight loss during radiation therapy. Otolaryngol Head Neck
Surg 2001; 125(6): 645-648.
https://doi.org/10.1067/mhn.2001.120428.
Iro H, Fietkau R, Kolb S. [Nutrition of ENT tumor patients
treated with radiotherapy. Comparison of oral and enteral
nutrition using percutaneous gastrostomy]. HNO 1989; 37(8):
-348.
Anwander T, Bergé S, Appel T, von Lindern JJ, Martini M,
Mommsen J, et al. Percutaneous endoscopic gastrostomy for
long-term feeding of patients with oropharyngeal tumors. Nutr
Cancer 2004; 50(1): 40-45.
https://doi.org/10.1207/s15327914nc5001_6.
Setton J, Lee NY, Riaz N, Huang SH, Waldron J, O'Sullivan B, et
al. A multi-institution pooled analysis of gastrostomy tube
dependence in patients with oropharyngeal cancer treated with
definitive intensity-modulated radiotherapy. Cancer 2015; 121(2):
-301. https://doi.org/10.1002/cncr.29022.
Fietkau R, Iro H, Sailer D, Sauer R. Percutaneous endoscopically
guided gastrostomy in patients with head and neck cancer.
Recent Results Cancer Res 1991; 121: 269-82.
https://doi.org/10.1007/978-3-642-84138-5_31.
Piquet MA, Ozsahin M, Larpin I, Zouhair A, Coti P, Monney M,
et al. Early nutritional intervention in oropharyngeal cancer
patients undergoing radiotherapy. Support Care Cancer 2002;
(6): 502-504. https://doi.org/10.1007/s00520-002-0364-1.
Beer KT, Krause KB, Zuercher T, Stanga Z. Early percutaneous
endoscopic gastrostomy insertion maintains nutritional state in
patients with aerodigestive tract cancer. Nutr Cancer 2005; 52(1):
-34. https://doi.org/10.1207/s15327914nc5201_4.
Nguyen NP, North D, Smith HJ, Dutta S, Alfieri A, Karlsson U,
et al. Safety and effectiveness of prophylactic gastrostomy tubes
for head and neck cancer patients undergoing chemoradiation.
Surg Oncol 2006; 15(4): 199-203.
https://doi.org/10.1016/j.suronc.2006.12.002.
Wiggenraad RG, Flierman L, Goossens A, Brand R, Verschuur
HP, Croll GA, et al. Prophylactic gastrostomy placement and
early tube feeding may limit loss of weight during chemoradiotherapy for advanced head and neck cancer, a preliminary
study. Clin Otolaryngol 2007; 32(5): 384-390.
https://doi.org/10.1111/j.1749-4486.2007.01533.x.
Bourhis J, Sire C, Graff P, Grégoire V, Maingon P, Calais G, et al.
Concomitant chemoradiotherapy versus acceleration of
radiotherapy with or without concomitant chemotherapy in
locally advanced head and neck carcinoma (GORTEC 99-02): an
Downloads
Published
Issue
Section
How to Cite
